High proton relaxivity for gadolinium oxide nanoparticles

Magnetic Resonance Materials in Physics, Biology and Medicine

Volumn 19, Issue 4, 2006, Pages 180-186

  Engström, Maria ^a   Klasson, Anna ^a   Pedersen, Henrik ^a   Vahlberg, Cecilia ^a   Käll, Per Olov ^a   Uvdal, Kajsa ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Contrast agent; Gd2O3; MRI; Nanoparticle; Relaxivity

Indexed keywords

CONTRAST MEDIUM; DIETHYLENE GLYCOL; GADOLINIUM; GADOLINIUM OXIDE; GADOLINIUM PENTETATE; NANOCRYSTAL; NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL CELL; AQUEOUS SOLUTION; ARTICLE; CONTRAST ENHANCEMENT; CULTURE MEDIUM; MEASUREMENT; MOLECULAR WEIGHT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATION; PRIORITY JOURNAL; SIGNAL NOISE RATIO; SIMULATION; SYNTHESIS; X RAY PHOTOELECTRON SPECTROSCOPY;

DOSE-RESPONSE RELATIONSHIP, DRUG; GADOLINIUM; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; NANOTECHNOLOGY; POLYMERS; PROTONS; SPECTROMETRY, X-RAY EMISSION; TIME FACTORS;

EID: 33748956835     PISSN: 09685243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10334-006-0039-x     Document Type: Article

References (27)

1. Jaffer FA, Weissleder R (2005) Molecular imaging in the clinical arena. J Am Med Assoc 293:855-862
2. Gillies RJ (2002) In vivo molecular imaging. J Cell Biochem 39:231-238
3. Dijkhuizen RM, Nicolay K (2003) Magnetic resonance imaging in experimental brain model of brain disorders. J Cerebr Blood Flow Metabol 23:1383-1402
4. Wickline SA, Lanza GM (2002) Molecular imaging, targeted therapeutics, and nanoscience. J Cell Biochem S39:90-97
5. McDonald MA, Watkin KL (2004) Investigation into the structure and magnetic properties of dextran small particulate gadolinium oxide nanoparticles. In: 12th scientific meeting and exhibition, International Society for Magnetic Resonance in Medicine (ISMRM), Kyoto, Japan, p 1718
6. McDonald MA, Watkin KL (2003) Small particulate gadolinium oxide and gadolinium oxide albumin microspheres as multimodal contrast and therapeutic agents. Invest Radiol 38:305-310
7. 3 nanocrystals functionalised by organic acids. J Colloid Interface Sci 288:140-148
8. Feldmann C (2003) Polyol-mediated synthesis of nanoscale functional materials. Adv Funct Mater 13:101-107
9. Bazzi R, Flores-Gonzalez MA, Louis C, Lebbou K, Durjardin C, Brenier A, Zhang W, Tillement O, Bernstein E, Perriat P (2003) Synthesis and luminescent properties of sub-5-nm lanthanide oxides nanoparticles. J Luminescence 102:445-450
10. 3:Eu. J Colloid Interface Sci 273:191-197
11. In den Kleef JJE, Cuppen JJM (1987) RLSQ: T1, T2 and RHO calculations, combining ratios and least squares. Magn Res Med 5:513-524
12. Raiser D, Deville JP (1991) Study of XPS photoemission of some gadolinium compounds. J Electron Spectrosc 57:91-97
13. Pedersen H, Söderlind F, Petoral RM, Uvdal K, Käll PO, Ojamäe L (2005) Surface interactions between Y(2)O(3) nanocrystals and organic molecules - an experimental and quantum-chemical study. Surf Sci 592:124-140
14. Hendrick RE, Haacke EM (1993) Basic physics of MR contrast agents and maximization of image contrast. J Magn Res Imag 3:137-148
15. Bloembergen N, Purcell EM, Pound RV (1948) Relaxation effects in nuclear magnetic resonance absorption. Phys Rev 73:679-712
16. Nelson TR, Tung SM (1987) Temperature dependence of proton relaxation times in vitro. Magn Reson Imag 5:189-199
17. Stanisz GJ, Henkelman RM (2000) Gd-DTPA relaxivity depends on macromolecular content. Magn Red Med 44:665-667
18. Lauffer RB (1987) Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem Rev 87:901-927
19. 3+ macrocyclic complex. J Am Chem Soc 119:4767-4768
20. III chelate. Chem Eur J 3:1499-1504
21. III chelates and anionic metabolites an aqueous solution: an NMR relaxometric study. Chem Eur J 9:2102-2109
22. Lowe MP, Parker D, Reany O, Aime S, Botta M, Castellano G, Gianolio E, Pagliarin R (2001) pH-dependent modulation of relaxivity and luminescence in macrocyclic gadolinium and europium complexes based on reversible intramolecular sulfonamide ligation. J Am Chem Soc 123:7601-7609
23. Reynolds CH, Annan N, Beshah K, Huber JH, Shaber SH, Lenkinski RE, Wortman JA (2000) Gadolinium-loaded nanoparticles: new contrast agents for magnetic resonance imaging. J Am Chem Soc 122:8940-8945
24. Cacheris WP, Quay SC, Rocklage SM (1990) The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn Res Imag 8:467-481
25. Bruemmel Y, Chan CP, Renneberg R, Thuenemann A, Seydack M (2004) On the influence of different surfaces in nano- and submicrometer particle based fluorescence immunoassays. Langmuir 20:9371-9379
26. 3 nanoparticles as fluorescent labels. Anal Chem 77:6864-6873
27. 3 rare earth nano-oxide. J Nanosci Nanotechnol 5:1448-1454